Biomet’s Earnings

Biomet (BMET) reported earnings of 42 cents a share this morning. That’s a penny below analysts’ consensus so the stock will probably be under pressure today. Sales were up just 5% to $508 million. The company said that sales at its trauma and spine unit (ick) were $12 million below management’s expectations. Over 330 jobs have been cut from that department. Biomet also said that its “comfortable” with second-quarter estimates of 44 cents to 46 cents a share, and sales of $519 million to $540 million.

Posted by on September 20th, 2006 at 8:52 am


The information in this blog post represents my own opinions and does not contain a recommendation for any particular security or investment. I or my affiliates may hold positions or other interests in securities mentioned in the Blog, please see my Disclaimer page for my full disclaimer.